Skip to main content

Table 2 Insertion procedure characteristics for fully enrolled patients

From: BioMonitor 2 in-office setting insertion safety and feasibility evaluation with device functionality assessment: results from the prospective cohort BioInsight study

Characteristic

Patients

N = 77

Device Orientation

 Position A

35 (45.5%)

 Position B

38 (49.4%)

 Position C

1 (1.3%)

 Other

3 (3.9%)

Final Incision Size (mm ± SD)a

14.9 ± 3.7

Total Procedure Duration (min ± SD)

8.4 ± 3.7

Prophylactic Antibiotic Use

29 (37.7%)

 After the procedureb

29 (37.7%)

 Before the procedure

3 (3.9%)

Oral Anticoagulant Use

34 (44.2%)

 Non-vitamin-K OAC

30 (39.0%)

 OACs not held prior to procedure

18 (23.4%)

Closure Materialb

 Deep tissue (subcutaneous) sutures

50 (64.9%)

 Superficial (dermal) sutures

23 (29.9%)

 Barbed sutures

13 (16.9%)

 Topical adhesive

48 (62.3%)

 Skin closure strips

5 (6.5%)

  1. Values are presented in n (%) unless otherwise indicated. OAC, oral anticoagulants. a3 patients missing final incision size. bMore than one closure material may have been used